EXELIXIS INC revenue breakdown overview

EXELIXIS INC revenue for the last year amounted to 2.09 B EUR, the most of which — 2.09 B EUR — came from its highest performing source at the moment, Medicines for Difficult-to-treat Cancers, the year earlier bringing 1.66 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought EXELIXIS INC 1.76 B EUR, and the year before that — 1.49 B EUR.